C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
12/2002
12/12/2002	WO2002098427A2 Sustained-release analgesic compounds
12/12/2002	US20020188124 Novel spiro compounds
12/12/2002	US20020187999 Anti-inflammatory uses of manzamines
12/12/2002	US20020187983 Process for the synthesis of derivatives of 2, 3-dihydro-1, 4-dioxino- [2, 3-f] quinoline
12/12/2002	CA2448665A1 Sustained-release analgesic compounds
12/12/2002	CA2445460A1 Carboline derivatives as pde-5 inhibitors
12/11/2002	EP1263762A1 Anti-infective ectatm
12/11/2002	EP1263759A2 Azaindoles
12/11/2002	CN1384833A Synthesis and methods of use of 9-substituted guanine derivatives
12/10/2002	US6492408 Peptidomimetic inhibitors of intercellular adhesion molecules binding to leukointegrins, such as lfa-1 and mac-1
12/10/2002	CA2092431C 3,9-diazabicyclo (3.3.1) nonan-7-yl derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them
12/05/2002	WO2002096907A1 Bicyclic nitrogen-containing heterocyclic derivatives for use as antibacterials
12/05/2002	WO2002096426A1 Hydantion derivatives as inhibitors of matrix metalloproteinases
12/05/2002	US20020183385 Administering a therapeutically effective amount of arsenic compounds to a mammal for treating solid tumor
12/05/2002	US20020183354 For therapy of depression and other diseases such as obsessive compulsive disorder, panic attacks, generalized anxiety disorder, social anxiety disorder, sexual dysfunction, eating disorders, obesity, addictive disorders
12/05/2002	US20020183353 For therapy of depression, obsessive compulsive disorder, panic attacks, generalized anxiety disorder, social anxiety disorder, sexual dysfunction, eating disorders, obesity, addictive disorders caused by ethanol or cocaine abuse
12/05/2002	US20020183352 Antidepressant indoletetrahydropyridine derivatives of 2,3-dihydro-7H-[1,4]dioxino[2,3-e]indole
12/05/2002	US20020183351 For therapy of depression, obsessive compulsive disorder, panic attacks, generalized anxiety disorder, social anxiety disorder, sexual dysfunction, eating disorders, obesity, addictive disorders caused by ethanol or cocaine abuse
12/05/2002	US20020183341 Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinazoline
12/05/2002	US20020183336 Azabicyclylmethyl derivatives of 7,8-dihydro-1,6,9-trioxa-3-aza-cyclopenta[a]naphthalene as 5-ht1a antagonists
12/05/2002	US20020183330 For therapy of schizophrenia, schizoaffective disorder, bipolar disorder, Parkinson's disease, L-DOPA induced psychoses or dyskinesias, Tourette's syndrome, hyperprolactinemia, or addiction to ethanol, nicotine, cocaine
12/05/2002	US20020183329 Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinoxaline
12/05/2002	US20020183322 Azabicyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinoline as 5-HT1A antagonists
12/05/2002	US20020182151 Aids therapy
12/05/2002	CA2447475A1 Hydantion derivatives as inhibitors of matrix metalloproteinases
12/04/2002	EP1262477A1 Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredient
12/04/2002	EP1261607A1 2,4-disubstituted thiazolyl derivatives
12/03/2002	US6489477 Nmda nr2b antagonists. accordingly, another aspect of the invention is the treatment of pain, migraine, depression, anxiety, schizophrenia, parkinson's disease, or stroke--maladies that are amenable to amelioration through
12/03/2002	US6489471 A process of synthesizing a carbapenem compound of formula (6) is disclosed, wherein r represents h or methyl, p and p* independently represent h or protecting groups and each r.sup.1 is independently selected from: h, halo, oh, op
11/2002
11/28/2002	US20020177609 Fatty alcohol drug conjugates
11/28/2002	US20020177600 Two or more ligand moieties covalently linked together by one or more linking groups enabling binding to multiple binding sites; increased efficacy, selectivity and duration; anti-proliferative and anticarcinogenic
11/28/2002	US20020177591 Central nervous system (CNS); diazabicyclo compounds such as 1,4-Diaza-bicyclo(3.2.2)nonane-4-carboxylic acid, 4-cyclohexyl-phenyl ester; CNS-penetrant alpha 7 nicotinic receptor agonist
11/28/2002	US20020177559 Inhibitors of cellular efflux pumps of microbes
11/27/2002	EP1259514A2 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors
11/27/2002	EP1259236A1 Tyrosine kinase inhibitors
11/27/2002	CN1381456A Pyrimidine-4-keto compound, its preparation method and medicine composition containing them
11/26/2002	CA2102889C Imidazo[1,2-a](pyrrolo, thieno or furano)[3,2-d]azepine derivatives, compositions and methods of use
11/26/2002	CA2076465C Cell binding agent conjugates of analogues and derivatives of cc-1065
11/21/2002	WO2002092602A2 PROCESSES FOR THE SYNTHESIS OF DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO-[2,3-f] QUINOLINE
11/21/2002	WO2002022598A8 Quinolinone derivatives as tyrosine kinase inhibitors
11/21/2002	US20020173654 Imidazonaphthyridine and tetrahydroimidazonaphthyridine compounds induce the biosynthesis of cytokines such as interferon and tumor necrosis factor, and useful as viricides and antitumor agents
11/21/2002	US20020173445 Selective androgen receptor modulators and methods for their identification, design and use
11/21/2002	CA2447150A1 Processes for the synthesis of derivatives of 2,3-dihydro-1,4-dioxino-[2,3-f] quinoline
11/20/2002	EP0656360B1 Trifluoromethylpyrroloindole carboxylic ester derivative and process for producing the same
11/19/2002	US6482845 Method for inhibiting interleukin-2 production using tricyclo compounds
11/14/2002	WO2002090362A1 Azaheterocyclylmethyl derivatives of 7,8-dihydro-1,6,9-trioxa-3-aza-cyclopenta[a]naphthalene as 5-ht1a antagonists
11/14/2002	WO2002090357A1 Disubstituted 1,7-guanines
11/14/2002	WO2002089806A1 Heterobicycles fkbp-ligands
11/14/2002	WO2002076399A3 YOHIMBINE DIMERS EXHIBITING BINDING SELECTIVITES FOR α2 ADRENERGIC RECEPTORS
11/14/2002	US20020169178 Benzothieno[3,2-c]pyridines as alpha2 antagonists
11/14/2002	US20020169155 A nitrogen-ring containing triheterocyclic compound is useful for treating a disease associated with aberrant leukocyte recruitment and/or activation
11/14/2002	CA2446795A1 Sulfamide, sulfamate, sulfonamide, urea, amide, alpha, alpha-difluoro amide oxalyl diamide, and heterobicycles fkbp-binding ligands
11/13/2002	EP1256583A1 Pyrimidine-4-one derivatives, process for their preparation and pharmaceutical compositions containing them
11/13/2002	EP1256582A1 1h-imidazopyridine derivatives
11/13/2002	EP1256581A1 Preventive or therapeutic agents for gastric or esophageal regurgitation
11/13/2002	EP1255739A1 3-aminoquinazolin-2,4-dione antibacterial agents
11/13/2002	EP1090006A4 Alkyl ether analogs of chlorins having an n-substituted imide ring
11/13/2002	EP0846119B1 Thienopyrimidine derivatives, their production and use as endothelin antagonists
11/13/2002	CN1379777A Amino-triazolopyridine derivatives
11/12/2002	CA2103242C Imidazo[2,1-b][3]benzazepine derivatives, compositions and method of use
11/07/2002	WO2002088274A1 Double-spiro organic compounds and electroluminescent devices
11/07/2002	WO2002088147A1 Sulfate of cephem compound
11/07/2002	WO2002088146A2 ANTIDEPRESSANT INDOLETETRAHYDROPYRIDINE DERIVATIVES OF 2,3-DIHYDRO-7H-[1,4]DIOXINO[2,3-e]INDOLE
11/07/2002	WO2002088145A1 AZABICYCLYLMETHYL DERIVATIVES OF 7,8-DIHYDRO-1,6,9-TRIOXA-3-AZACYCLOPENTA[a]NAPHTHALENE AS 5-HT1A ANTAGONISTS
11/07/2002	WO2002088144A2 ANTIDEPRESSANT AZAHETEROCYCLYLMETHYL DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO[2,3-f]QUINOXALINE
11/07/2002	WO2002088143A2 Dihydroimidazo[4,5-e]indole and 7h-pyrrolo[3,2-f]quinoxaline derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands
11/07/2002	WO2002088140A1 Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-1,6,9-trioxa-3-aza-cyclopenta[a]naphthalene
11/07/2002	WO2002088139A1 6h-oxazolo[4,5-e]indole derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands
11/07/2002	WO2002088135A1 Antidepressant azaheterocyclylmethyl derivatives of oxaheterocycle-fused-[1,4]-benzodioxans
11/07/2002	WO2002088132A1 Azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinoline as 5-ht1aantagonists
11/07/2002	WO2002088131A1 Antidepressant (sssri) azaheterocyclymethyl derivatives of 7,8-dihydro-3h-t,9-dioxa-1,3-diazacyclopenta[a]naphthalene
11/07/2002	WO2002088130A1 Azabicyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino-[2,3-f]quinoline as 5-ht1a antagonists
11/07/2002	WO2002088129A1 Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinazoline
11/07/2002	WO2001042243A3 Protein kinase inhibitors
11/07/2002	US20020165391 Novel spiro compounds
11/07/2002	US20020165365 Synthetic catalyst for selective cleavage of protein and method for selective cleavage of protein using the same
11/07/2002	US20020165245 Antidepressant azaheterocyclymethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinoline
11/07/2002	US20020165241 Such as 4-((methyl-pyrimidin-2-ylamino)-methyl)-piperidine-1-carboxylic acid benzyl ester; useful for pain relief; treating migraine, depression, anxiety, schizophrenia, Parkinson's disease, and stroke; N-methyl-D-aspartate (NMDA)
11/07/2002	CA2445859A1 Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-1,6,9-trioxa-3-aza-cyclopenta[a]naphthalene
11/07/2002	CA2445583A1 Antidepressant indoletetrahydropyridine derivatives of 2,3-dihydro-7h-[1,4]dioxino[2,3-e]indole
11/07/2002	CA2445581A1 Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinoxaline
11/07/2002	CA2445552A1 Antidepressant (sssri) azaheterocyclymethyl derivatives of 7,8-dihydro-3h-t,9-dioxa-1,3-diazacyclopenta[a]naphthalene
11/07/2002	CA2445543A1 Antidepressant azaheterocyclylmethyl derivatives of oxaheterocycle-fused-¬1,4\|-benzodioxans
11/07/2002	CA2444897A1 Sulfate of cephem compound
11/06/2002	EP1254908A1 Preparation of a camptothecin derivative by intramolecular cyclisation
11/06/2002	EP0758335B1 Preparation of a camptothecin derivative by intramolecular cyclisation
11/05/2002	US6476066 Anti-first-pass effect compounds
11/05/2002	US6476029 7-alkyl- and cycloalkyl-substituted imidazotriazinones
10/2002
10/31/2002	WO2002085912A1 ANTIPSYCHOTIC AMINOMETHYL DERIVATIVES OF 7,8-DIHYDRO-3H-6,9-DIOXA-1,3-DIAZA-CYCLOPENTA[a]NAPHTHALENE
10/31/2002	WO2002085886A2 Chiral, broad-spectrum antibacterial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation and compositions
10/31/2002	WO2002085413A1 Synthetic catalyst for selective cleavage of protein and method for selective cleavage of protein using the same
10/31/2002	US20020161001 Heterocyclic compounds, which are inhibitors of the enzyme DPP-IV
10/31/2002	DE10121217A1 6H-Oxazolo[4,5-e]indol-Derivate als nikotinische Acetylcholinrezeptor Liganden und/oder serotonerge Liganden 6H-oxazolo [4,5-e] indole derivatives as nicotinic acetylcholine receptor ligands and / or serotonergic ligands
10/31/2002	DE10121215A1 Dihydro-imidazo[4,5-e]indol- und 7H-Pyrrolo[3,2-f]chinoxalin Derivate als nikotinische Acetylcholinrezeptor Liganden und/oder serotonerge Liganden Dihydro-imidazo [4,5-e] indole and 7H-pyrrolo [3,2-f] quinoxaline derivatives as nicotinic acetylcholine receptor ligands and / or serotonergic ligands
10/31/2002	CA2445888A1 Chiral, broad-spectrum antibacterial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation and compositions
10/29/2002	US6472527 New heterocyclic compounds are disclosed which are used as intermediates for the preparation of trans-thiazine-indigo pigments which are in part new compounds and can be used for the mass pigmentation of organic substrates.
10/24/2002	WO2002083678A1 Tricyclic diazepines as tocolytic oxytocin receptor antagonists
10/24/2002	WO2002030931A3 Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
10/24/2002	US20020156081 Pyrazolopyrimidines as therapeutic agents
10/24/2002	US20020155484 Oligonucleotide for use as tool in the detection of preferential compounds in solution

1 ... 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 ... 111